Opportunity Information: Apply for CDC RFA GH16 1603
Apply for CDC RFA GH16 1603
- The HHS-CDC-CGH in the health sector is offering a public funding opportunity titled "Economics, finance, and budgetary evidence to support sustainable financing, planning and decision-making for immunization programs" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.185.
- This funding opportunity was created on Dec 23, 2015 and posted on Dec 23, 2015.
- Applicants must submit their applications by Feb 23, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Economics, finance, and budgetary evidence to support sustainable financing, planning and decision-making for immunization programs" (Funding Opportunity Number: CDC RFA GH16-1603) was a CDC cooperative agreement designed to strengthen how low- and lower-middle-income countries plan, cost, finance, and govern their immunization programs. Housed under HHS/CDC/Center for Global Health and aligned with the health assistance listing (CFDA) 93.185, the core aim was to help countries move beyond short-term, donor-reliant approaches by building durable national capacity to make evidence-based decisions about vaccines and immunization delivery, backed by solid economic and budgetary analysis.
A central feature of the project was peer-to-peer learning through the creation of Centers of Excellence (COEs) in three countries. The concept is that seeing practical, working examples of strong decision-making systems, accurate immunization program costing, innovative financing approaches, and effective legislative processes in a comparable setting is one of the fastest ways for policymakers and technical teams to adopt those practices at home. In other words, the COEs would function as real-world demonstration hubs where peers can observe how evidence is gathered and used, how immunization costs are calculated and defended in budget processes, how financing strategies are structured, and how laws or regulations can support long-term program sustainability.
The opportunity emphasized institutionalizing these best practices, not just producing one-off analyses. By embedding rigorous costing, budget planning, and finance decision processes into routine government operations, participating countries could strengthen credibility with vaccine manufacturers and suppliers. The notice explicitly links this to market dynamics: when countries can demonstrate they have the technical and financial readiness to negotiate, budget, and purchase vaccines reliably, manufacturers may be more willing to engage competitively. Over time, this is intended to support a fairer, more competitive global vaccine market, especially for countries that historically have had less bargaining power.
Another important aspect is that the grant framed immunization financing capacity as a platform that can spill over into broader public finance challenges. Skills like program costing, expenditure tracking, budget advocacy grounded in evidence, and navigating legislative pathways are not unique to immunization; once built, they can be applied to other health programs and even other sectors. The opportunity also positioned this work as supporting progress toward the Global Vaccine Action Plan (GVAP) 2020 Strategic Objectives, reflecting an intent to connect national financing and planning improvements with global immunization performance goals.
Administratively, this was a discretionary funding opportunity using a cooperative agreement mechanism, which typically indicates substantial federal involvement in project planning, implementation support, or technical collaboration. Eligibility was listed as unrestricted (open to any type of entity, with any limits only as clarified in the full announcement). The funding details indicated an award ceiling of $1,000,000, with an expectation of two awards. The opportunity was posted and created on December 23, 2015, and it closed on February 23, 2016, meaning it was a time-limited competition focused on launching the COE-driven approach within that funding window.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Economics, finance, and budgetary evidence to support sustainable financing, planning and decision-making for immunization programs."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA GH16-1603.
Which agency and program issued this opportunity?
This was a CDC cooperative agreement housed under HHS/CDC/Center for Global Health.
What is the associated CFDA / Health Assistance Listing number?
The opportunity is aligned with CFDA (Health Assistance Listing) 93.185.
What was the core purpose of the cooperative agreement?
The core purpose was to strengthen how low- and lower-middle-income countries plan, cost, finance, and govern their immunization programs, with an emphasis on building durable national capacity for evidence-based decision-making backed by economic and budgetary analysis.
Which countries were the focus of this work?
The notice described a focus on low- and lower-middle-income countries.
How does the opportunity address donor reliance and short-term planning?
It aimed to help countries move beyond short-term, donor-reliant approaches by strengthening national systems and routine processes for immunization costing, budgeting, financing, and governance.
What is meant by "Centers of Excellence (COEs)" in this opportunity?
Centers of Excellence were intended to be created in three countries and function as practical, real-world demonstration hubs where peers can observe strong decision-making systems, accurate immunization program costing, innovative financing approaches, and effective legislative processes that support sustainability.
How many Centers of Excellence were planned?
Three Centers of Excellence were planned (in three countries).
Why did the opportunity emphasize peer-to-peer learning?
The concept was that seeing working examples in a comparable setting can accelerate adoption of best practices by policymakers and technical teams in other countries, especially for decision-making, costing, financing strategies, and legislative support for immunization programs.
What kinds of practices were COEs expected to demonstrate?
The COEs were described as demonstrating: how evidence is gathered and used in decisions, how immunization costs are calculated and defended during budget processes, how financing strategies are structured, and how laws or regulations can support long-term sustainability.
Was the goal to produce one-time analyses or longer-term systems?
The opportunity emphasized institutionalizing best practices rather than producing one-off analyses, with a focus on embedding rigorous costing, budget planning, and finance decision processes into routine government operations.
How does building financing and budgeting capacity affect vaccine procurement and supplier relationships?
The notice linked stronger planning and financing systems to increased credibility with vaccine manufacturers and suppliers. When countries can demonstrate technical and financial readiness to negotiate, budget, and purchase vaccines reliably, manufacturers may be more willing to engage competitively.
What broader market impact did the opportunity claim to support?
Over time, it was intended to support a fairer, more competitive global vaccine market, particularly for countries that historically have had less bargaining power.
Does the opportunity suggest benefits beyond immunization programs?
Yes. It framed immunization financing capacity as a platform that can spill over into broader public finance challenges. Skills like program costing, expenditure tracking, evidence-based budget advocacy, and navigating legislative pathways can be applied to other health programs and even other sectors.
How does this opportunity connect to global immunization goals?
It was positioned as supporting progress toward the Global Vaccine Action Plan (GVAP) 2020 Strategic Objectives by linking national financing and planning improvements with broader immunization performance goals.
What type of funding mechanism was used?
This was a discretionary funding opportunity using a cooperative agreement mechanism.
What does a cooperative agreement imply about CDC involvement?
The description notes that a cooperative agreement typically indicates substantial federal involvement, such as participation in project planning, implementation support, or technical collaboration.
Who was eligible to apply?
Eligibility was listed as unrestricted (open to any type of entity), with any limits only as clarified in the full announcement.
What was the maximum award amount (award ceiling)?
The award ceiling was $1,000,000.
How many awards were expected?
The opportunity indicated an expectation of two awards.
When was the opportunity posted and created?
It was posted and created on December 23, 2015.
When did the opportunity close?
The closing date was February 23, 2016.
Was this an ongoing opportunity or a time-limited competition?
It was a time-limited competition, with the application window running from late December 2015 to late February 2016, focused on launching the COE-driven approach within that period.
Browse more opportunities from the same category: Health
Next opportunity: PROMOTING INCLUSIVE DEVELOPMENT IN SOUTHERN AFRICA
Previous opportunity: OJJDP FY 16 Alaska Native Youth Training and Technical Assistance Project
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH16 1603
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH16 1603) also looked into and applied for these:
| Funding Opportunity |
|---|
| Health Promotion and Disease Prevention Centers: Special Interest Project Competitive Supplements (SIPS) Apply for RFA DP 16 006 Funding Number: RFA DP 16 006 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: Case Dependent |
| Organized Approaches to Increase Colorectal Cancer Screening Apply for CDC RFA DP15 150202CONT16 Funding Number: CDC RFA DP15 150202CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Building Effective Health Information Systems Under PEPFAR Apply for CDC RFA GH15 153502CONT16 Funding Number: CDC RFA GH15 153502CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Expansion of HIV/AIDS, STI and TB Laboratory Activities in the Namibia Institute of Pathology (NIP), Ltd under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS09 955SUPP16 Funding Number: CDC RFA PS09 955SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Procurement, Logistics Management, Warehousing, and Distribution of HIV/AIDS, TB-Related Commodities, Vaccines, Equipment and Services, and Supply Chain Systems Strengthening in Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1665 Funding Number: CDC RFA GH16 1665 Agency: HHS-CDC-CGH Category: Health Funding Amount: $80,000,000 |
| Telehealth Resource Center Grant Program Apply for HRSA 16 013 Funding Number: HRSA 16 013 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Supporting the National Blood Transfusion Service in the Implementation and Expansion of Blood Safety Activities in Ethiopia under the President’s Emergency Plan for AIDS Relief Apply for CDC RFA PS10 10111SUPP16 Funding Number: CDC RFA PS10 10111SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Small Health Care Provider Quality Improvement Program Apply for HRSA 16 019 Funding Number: HRSA 16 019 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Building Human Resource Capacity within the Ministry of Health and Social Services in the Republic of Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1096SUPP16 Funding Number: CDC RFA PS10 1096SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Accountable Health Communities Apply for CMS 1P1 17 001 Funding Number: CMS 1P1 17 001 Agency: HHS-CMS Category: Health Funding Amount: $4,510,000 |
| Civil Society Capacity Building for Advocacy and Response to the HIV/AIDS Epidemic among key populations Apply for CDC RFA GH14 141103CONT16 Funding Number: CDC RFA GH14 141103CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Operations Research (Implementation Science) for Strengthening Program Implementation through the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for RFA GH 16 005 Funding Number: RFA GH 16 005 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: $500,000 |
| Mozambique: Supporting Indigenous Organizations to implement and Expand Comprehensive HIV/AIDS Prevention, Care and Treatment in the Republic of Mozambique under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1130SUPP16 Funding Number: CDC RFA GH11 1130SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Meeting PEPFAR’s accelerated targets for HIV in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1556SUPP16 Funding Number: CDC RFA GH15 1556SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Strengthening Local Capacity to Provide Sustainable HIV-Related Care and Treatment Services in South Africa under PEPFAR Apply for CDC RFA GH11 1109SUPP16 Funding Number: CDC RFA GH11 1109SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in the Republic of South Africa under PEPFAR Apply for CDC RFA GH11 1152SUPP16 Funding Number: CDC RFA GH11 1152SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Support for Strengthening and Expanding HIV/AIDS Surveillance Activities in South Africa under PEPFAR Apply for CDC RFA GH11 1154SUPP16 Funding Number: CDC RFA GH11 1154SUPP16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| The USAID Global Health Development Innovation Accelerator Broad Agency Announcement (BAA) Addendum 03 Apply for BAA GLOBALHEALTH 2016 Funding Number: BAA GLOBALHEALTH 2016 Agency: USAID Category: Health Funding Amount: Case Dependent |
| Centers for Disease Control and Prevention Reduce Hepatitis Infections by Treatment and Integrated Prevention Services (Hepatitis-TIPS) among Non-urban Young Persons Who Inject Drugs Apply for RFA PS 14 00403CONT16 Funding Number: RFA PS 14 00403CONT16 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: Case Dependent |
| NIDCR Small Research Grants for Data Analysis and Statistical Methodology Applied to Genome-wide Data (R03) Apply for PAR 16 070 Funding Number: PAR 16 070 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH16 1603", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.